{"id":59387,"date":"2024-02-28T05:55:36","date_gmt":"2024-02-28T05:55:36","guid":{"rendered":"https:\/\/medsname.com\/nepalact-eye-drops\/"},"modified":"2026-04-30T10:23:58","modified_gmt":"2026-04-30T10:23:58","slug":"nepalact-eye-drops","status":"publish","type":"product","link":"https:\/\/medsbase.com\/da\/nepalact-eye-drops\/","title":{"rendered":"Nepalact \u00f8jendr\u00e5ber"},"content":{"rendered":"<p><!-- medsbase-tldr-answer --><\/p>\n<div class=\"medsbase-tldr-answer\" style=\"background:#fffbe6;border-left:4px solid #f5a623;padding:14px 18px;margin:14px 0 22px;border-radius:6px;font-size:15px;line-height:1.55;\">\n<h3 style=\"margin:0 0 6px;font-size:17px;color:#8a6d3b;\">\u26a1 Quick Answer \u2014 What is Nepalact Eye Drops?<\/h3>\n<p style=\"margin:0;\">Nepalact Eye Drops is Nepafenac 0.1%, a topical NSAID eye drop for post-operative pain and inflammation, allergic conjunctivitis, and prevention of cystoid macular oedema after cataract surgery. Used 2\u20134 times daily.<\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background:#f6f7fb;border:1px solid #e3e5ee;border-radius:8px;padding:14px 18px;margin:18px 0;font-size:14px;line-height:1.55;\"><strong style=\"color:#1f3661;\">Hvorfor bestille fra MedsBase?<\/strong> Produceret af en WHO-GMP-certificeret fabrikant \u00b7 Diskret emballage \u00b7 Verdensomsp\u00e6ndende forsendelse \u00b7 <a href=\"\/da\/reviews\/\" rel=\"noopener\">1.400+ verificerede kundeanmeldelser<\/a><\/div>\n<p class=\"medsbase-reship-line\" style=\"font-size:14px;color:#444;margin:8px 0 18px;\">\ud83d\udce6 Hver ordre er d\u00e6kket af vores <a href=\"https:\/\/medsbase.com\/da\/medsbase-re-shipment-assurance-policy\/\"><strong>Reshipment Assurance Policy<\/strong><\/a> \u2014 hvis din pakke ikke ankommer inden for 20 hverdage, sender vi en erstatning.<\/p>\n<h3>Hvorfor bestille fra MedsBase<\/h3>\n<p>Nepalact Eye Drops is sourced from a WHO-GMP certified manufacturer and shipped worldwide in plain, discreet packaging. Every order is covered by our <a href=\"\/da\/medsbase-re-shipment-assurance-policy\/\" rel=\"noopener\">Reshipment Assurance Policy<\/a> \u2014 hvis den ikke er ankommet inden for 20 hverdage, sender vi en ny uden ekstra omkostninger. Underst\u00f8ttet af 1.400+ verificerede kundeanmeldelser.<\/p>\n<h2>What is Nepalact Eye Drops?<\/h2>\n<p>Nepalact Eye Drops is manufactured by Sun Pharma and contains Nepafenac 0.1% as a sterile ophthalmic solution. Topical NSAIDs reduce inflammation by blocking cyclo-oxygenase (COX) enzymes, decreasing prostaglandin production. They are non-steroidal and avoid the IOP elevation, cataract risk, and immune-suppression issues of topical steroids.<\/p>\n<h2>S\u00e5dan virker det<\/h2>\n<p>Nepafenac inhibits both COX-1 and COX-2 (as an inactive prodrug that is converted to active amfenac in the eye) in ocular tissues. The result is reduced prostaglandin synthesis, less leukocyte trafficking, and decreased miosis, pain, and inflammation.<\/p>\n<h2>Indikationer<\/h2>\n<ul>\n<li><strong>Postoperativ okul\u00e6r inflammation<\/strong> efter kataraktkirurgi, refraktiv kirurgi, korneal cross-linking<\/li>\n<li><strong>Profylakse mod cystoid makula\u00f8dem (CME)<\/strong> efter kataraktkirurgi \u2014 is\u00e6r hos diabetikere, tidligere CME eller epiretinal membran<\/li>\n<li><strong>Opretholdelse af intraoperativ mydriasis<\/strong> under kataraktkirurgi (reducerer miosis fra prostaglandinfrigivelse)<\/li>\n<li><strong>S\u00e6sonbestemt allergisk konjunktivitis<\/strong> \u2014 ikke f\u00f8rstevalg, men nyttig n\u00e5r antihistaminer ikke er tilstr\u00e6kkelige<\/li>\n<li><strong>Postoperativ smertekontrol<\/strong> \u2014 reducerer narkotikabrug efter refraktiv kirurgi<\/li>\n<\/ul>\n<h2>Dosering<\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:14px 0;\">\n<thead>\n<tr style=\"background:#2c7cb0;color:#fff;\">\n<th style=\"padding:8px;text-align:left;border:1px solid #ddd;\">Indikation<\/th>\n<th style=\"padding:8px;text-align:left;border:1px solid #ddd;\">Dosis<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding:8px;border:1px solid #ddd;\">Postkatarakt inflammation<\/td>\n<td style=\"padding:8px;border:1px solid #ddd;\">1 drop three times daily for 2 weeks<\/td>\n<\/tr>\n<tr style=\"background:#f9f9f9;\">\n<td style=\"padding:8px;border:1px solid #ddd;\">CME-profylakse (h\u00f8j risiko)<\/td>\n<td style=\"padding:8px;border:1px solid #ddd;\">Pr\u00e6-op i 1\u20133 dage og forts\u00e6t 4\u20136 uger post-op<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:8px;border:1px solid #ddd;\">Allergisk konjunktivitis<\/td>\n<td style=\"padding:8px;border:1px solid #ddd;\">1 dr\u00e5be fire gange dagligt efter behov<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<div style=\"background:#fff3f3;border-left:4px solid #d9534f;padding:12px 16px;margin:14px 0;border-radius:4px;font-size:14px;line-height:1.55;\"><strong style=\"color:#a94442;\">Risiko for hornhindesmeltning ved langvarig brug.<\/strong> Topiske NSAID'er har sj\u00e6ldent for\u00e5rsaget nedbrydning af hornhindeepitel, stromal fortyndning og hornhindeperforation, is\u00e6r ved langvarig brug (&gt; 2 uger), hos patienter med allerede eksisterende hornhindesygdom (t\u00f8rre \u00f8jne, neurotrof keratitis, herpes) og hos diabetikere med nedsat hornhindef\u00f8lsomhed. V\u00e6r opm\u00e6rksom p\u00e5 uforklarlig forv\u00e6rring af smerter, nedsat syn eller ny hornhindefarvning \u2014 stop \u00f8jeblikkeligt og s\u00f8g \u00f8jenl\u00e6geunders\u00f8gelse.<\/div>\n<h2>Bivirkninger<\/h2>\n<p><strong>Lokalt:<\/strong> stikken ved inddrypning (mest almindelig), konjunktival hyper\u00e6mi, fremmedlegemsfornemmelse, midlertidigt sl\u00f8ret syn, \u00f8jenkl\u00f8e, hornhindefarvning ved langvarig brug.<\/p>\n<p><strong>Overf\u00f8lsomhed:<\/strong> sj\u00e6lden bronkospasme hos aspirinf\u00f8lsomme patienter, n\u00e6ldefeber, angio\u00f8dem.<\/p>\n<h2>Advarsler &amp; Kontraindikationer<\/h2>\n<ul>\n<li>Astma induceret af aspirin eller NSAID \u2014 relativ kontraindikation<\/li>\n<li>Allerede eksisterende hornhindesygdom (alvorlig t\u00f8rhed i \u00f8jnene, neurotrof keratitis, herpes) \u2014 \u00f8get risiko for hornhindesmeltning<\/li>\n<li>Diabetisk keratopati \u2014 \u00f8get smeltningsrisiko<\/li>\n<li>Samtidig topisk steroid \u2014 additiv hornhindetoksicitet<\/li>\n<li>Bl\u00f8dningstendens eller antikoagulantia-brug \u2014 mindre risiko for intraoperativ bl\u00f8dning, hvis det anvendes pr\u00e6operativt<\/li>\n<li>Sen graviditet (tredje trimester) \u2014 undg\u00e5 (teoretisk risiko for for tidlig lukning af ductus arteriosus ved systemisk absorption; minimal ved \u00f8jendr\u00e5ber)<\/li>\n<li>B\u00f8rn \u2014 normalt sikkert over 3 \u00e5r; sj\u00e6ldent brugt under den alder<\/li>\n<\/ul>\n<h2>Opbevaring<\/h2>\n<p>Opbevares ved 15\u201325\u00b0C beskyttet mod lys. Kasseres 28 dage efter f\u00f8rste \u00e5bning.<\/p>\n<h2 id=\"faqs\">Ofte stillede sp\u00f8rgsm\u00e5l<\/h2>\n<h3>What is Nepalact Eye Drops used for?<\/h3>\n<p>Mest almindeligt efter kataraktoperation for at reducere inflammation, kontrollere smerter og forhindre cystoid makula\u00f8dem. Bruges ogs\u00e5 til allergisk konjunktivitis, refraktiv kirurgi-genopretning og som et alternativ til steroider hos patienter med steroidrespons.<\/p>\n<h3>How is Nepalact Eye Drops different from a steroid eye drop?<\/h3>\n<p>NSAID'er blokerer prostaglandinsyntesen uden at p\u00e5virke det bredere immunrespons. De \u00f8ger ikke IOP, for\u00e5rsager ikke katarakt og fremmer ikke viral eller svampeinfektion \u2014 hvilket g\u00f8r dem sikrere til langvarig brug. De er ogs\u00e5 mindre potente ved alvorlig inflammation; steroider foretr\u00e6kkes stadig ved aktiv uveitis.<\/p>\n<h3>Why is Nepalact Eye Drops used after cataract surgery?<\/h3>\n<p>Prostaglandiner frigivet under operationen for\u00e5rsager smerter, miosis og bidrager til cystoid makula\u00f8dem (en almindelig \u00e5rsag til synstab efter kataraktoperation). NSAID'er d\u00e6mper denne reaktion. Mange oftalmologer bruger NSAID'er sammen med steroider i de f\u00f8rste 2 uger, hvorefter de forts\u00e6tter med kun NSAID i 4\u20136 uger i \u00f8jne med h\u00f8j CME-risiko.<\/p>\n<h3>Hvad er hornhindesmeltning?<\/h3>\n<p>Sj\u00e6ldent, men alvorligt \u2014 hornhindeepitheliet nedbrydes, og den underliggende stroma tyndes, nogle gange med progression til perforation. Risikofaktorer: langvarig brug, pr\u00e6eksisterende hornhindesygdom, diabetes, samtidig topikal steroid. Stop dr\u00e5ben og s\u00f8g samme-dags vurdering for enhver uforklarlig forv\u00e6rring af smerter eller synstab.<\/p>\n<h3>Can I drive after using Nepalact Eye Drops?<\/h3>\n<p>Let sl\u00f8ring i 5\u201310 minutter efter inddrypning. Vent til synet er klart.<\/p>\n<h3>Is Nepalact Eye Drops safe in pregnancy?<\/h3>\n<p>Topikal absorption er minimal. Undg\u00e5 i tredje trimester (teoretisk risiko for for tidlig lukning af ductus arteriosus med systemiske NSAID'er). Generelt sikkert i tidligere graviditet, n\u00e5r det er klart indikeret.<\/p>\n<h3>Can I use Nepalact Eye Drops with a steroid eye drop?<\/h3>\n<p>Ja, men v\u00e6r opm\u00e6rksom p\u00e5 additiv korneal toksicitet. Kombinationen er standard efter kataraktoperation i mange klinikker. Vent 5 minutter mellem flaskerne.<\/p>\n<h3>Hvad hvis jeg er aspirinf\u00f8lsom?<\/h3>\n<p>Krydsreaktivitet er mulig. Undg\u00e5 topiske NSAID'er, hvis du har en historie med aspirininduceret astma eller anafylaksi til orale NSAID'er.<\/p>\n<h3>Hvad hvis jeg glemmer en dosis?<\/h3>\n<p>Tag det s\u00e5 snart du husker det, medmindre den n\u00e6ste planlagte dosis er t\u00e6t p\u00e5.<\/p>\n<h3>Hvor lang er den typiske behandlingsperiode?<\/h3>\n<p>2\u20136 uger afh\u00e6ngigt af indikationen. Undg\u00e5 behandlingsperioder l\u00e6ngere end 6 uger, medmindre det er under specialistvejledning p\u00e5 grund af kumulativ korneal toksicitet.<\/p>\n<p><!-- medsbase-related-alts-v1 --><\/p>\n<h3>Anden \u00f8jenmedicin<\/h3>\n<p>Kunder, der ser dette produkt, overvejer ogs\u00e5 disse alternativer i vores <a href=\"\/da\/eye-care\/\">\u00d8jensundhed<\/a> sortiment:<\/p>\n<ul>\n<li><a href=\"https:\/\/medsbase.com\/da\/pred-forte-eye-drops\/\">Pred Forte (prednisolonacetat)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/da\/fml-eye-drop\/\">FML Eye Drop (fluorometholon)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/da\/lotepred-eye-drop\/\">Lotepred Eye Drop (loteprednol)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/da\/acular-ls-drop\/\">Acular LS (ketorolac)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/da\/megabrom-eye-drop\/\">Megabrom (bromfenac)<\/a><\/li>\n<\/ul>\n<h3>Medicinsk ansvarsfraskrivelse<\/h3>\n<p style=\"font-size:13px;color:#555;\">Informationen p\u00e5 denne side er kun til undervisningsform\u00e5l og er ikke en erstatning for medicinsk r\u00e5dgivning fra en kvalificeret \u00f8jenl\u00e6ge eller optiker. \u00d8jenlidelser kan hurtigt true synet \u2014 pludseligt synstab, st\u00e6rke smerter eller trauma er en akut \u00f8jenl\u00e6gehj\u00e6lp. Konsult\u00e9r altid en \u00f8jenplejefaglig f\u00f8r du p\u00e5begynder, stopper eller \u00e6ndrer en behandling.<\/p>","protected":false},"excerpt":{"rendered":"<p>Nepalact (nepafenac 0.1%) \u2014 prodrug NSAID eye drop activated to amfenac inside the cornea. Three-times-daily for post-cataract inflammation and macular-oedema prophylaxis.<\/p>","protected":false},"featured_media":59388,"comment_status":"open","ping_status":"open","template":"","meta":[],"product_brand":[],"product_cat":[3141,3343,3342],"product_tag":[4687,4688],"class_list":{"0":"post-59387","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-category-overview","7":"product_cat-eye-care","8":"product_cat-general-health","9":"product_tag-nepafenac","10":"product_tag-nepalact-eye-drops","12":"first","13":"instock","14":"shipping-taxable","15":"purchasable","16":"product-type-variable","17":"has-default-attributes"},"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/da\/wp-json\/wp\/v2\/product\/59387","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/da\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/da\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/da\/wp-json\/wp\/v2\/comments?post=59387"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/da\/wp-json\/wp\/v2\/media\/59388"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/da\/wp-json\/wp\/v2\/media?parent=59387"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/da\/wp-json\/wp\/v2\/product_brand?post=59387"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/da\/wp-json\/wp\/v2\/product_cat?post=59387"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/da\/wp-json\/wp\/v2\/product_tag?post=59387"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}